Form 4 for KYMR Kymera Therapeutics, Inc.
Accepted 2022-01-14 00:00:00 ET · period of report 2022-01-12 · accession 0000899243-22-002010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-01-14 | 2022-01-12 | KYMR | Jacobs Bruce N. | CFO | S - Sale+OE | $51.84 | -15.0K | 26.1K | -37% | -$777.7K |
| D | 2022-01-14 | 2022-01-12 | KYMR | Jacobs Bruce N. | CFO | M - OptEx | $2.08 | +15.0K | 32.5K | +86% | +$31.2K |
| D | 2022-01-14 | 2022-01-12 | KYMR | Jacobs Bruce N. | CFO | M - OptEx | $0.00 | -15.0K | 37.0K | -29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-12 | S | D | 7,151 | $52.13 | 18,936 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.71 to $52.59. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 2 | Common | Common Stock | 2022-01-12 | S | D | 1,422 | $53.27 | 17,514 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.01 to $53.50. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Common | Common Stock | 2022-01-12 | M | A | 15,000 | $2.08 | 32,514 | D | — | — | |
| 4 | Common | Common Stock | 2022-01-12 | S | D | 6,427 | $51.21 | 26,087 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.70 to $51.69. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 5 | Derivative | Stock Option (Right to Buy) | 2022-01-12 | M | D | 15,000 | $0.00 | 36,974 | D | $2.08 · — to 2029-08-28 | 15,000 Common Stock | (F5) The shares underlying this stock option shall vest upon the achievement of specified performance-based milestones. |